Celebrating 40 Years of Pride |
|
|
| New Department of Medicine Chair |
Anne Dixon, M.A., B.M.B.Ch., professor of medicine, has been appointed chair of the Department of Medicine in the Larner College of Medicine at the University of Vermont. Dixon has been serving as interim chair since October 2022. She succeeds Polly Parsons, M.D., who was chair from 2006–2022.
|
|
|
| Honoring Research Excellence |
UVM and the UVM Larner College of Medicine are delighted to announce the “Dean’s Celebration of Excellence in Research,” a weeklong celebration dedicated to showcasing the research endeavors of the Larner community, scheduled from September 18 to 22, 2023.
|
|
|
| Boosting Vt’s Physician Pipeline |
Cliff Reilly ’24 is the inaugural recipient of a scholarship that encourages Larner medical grads to return to practice in Vermont once they’ve completed their training. The incentive aims to strengthen the physician pipeline into Vermont and attract a geographically distributed physician workforce.
|
|
|
| “Ballet taught me discipline, resilience, and the power of mentorship. I remember my ballet teacher saying that corrections come from a place of care, pushing us to be our best selves. These lessons resonate as I step into the world of medicine, where learning never stops.”
—Marie Lim, Class of 2027
|
|
|
|
The Larner College of Medicine’s Translational Global Infectious Disease Research Center (TGIR), a Center of Biomedical Research Excellence (COBRE), has received Phase II funding from the National Institutes of Health’s National Institute of General Medical Sciences. The $11.5 million award provides an additional five years of funding for this successful research program, which began in 2018.
|
|
|
|
Several UVM Cancer Center members—including Drs. Chatterjee, Cunniff, Glass, Heath, Kinsey, Masquelin, Roberts, and Toth—have recently been awarded sizable grants with direct or some component of cancer relevance. Additionally, the Cancer Center has announced Drs. Anker, Howe, Janssen-Heininger, Langevin, and Stumpff as new members of its leadership team.
|
|
|
|
Nominated by their peers for “engaging in work rooted in improving health equity, anti-racism, and community engagement,” seven members of the Class of 2024 have been selected for induction into the newly formed Larner chapter of the Aequitas Health Honor Society. The mission of Aequitas is to identify, recognize, and develop future physician leaders to address glaring health inequities.
|
|
|
|
Twenty-four members of the Larner Class of 2024 have been selected for induction into the Alpha Omega Alpha (AΩA) Honor Medical Society on the basis of their “demonstrated excellence in leadership, research, professionalism, service to the school and community, and clinical acumen.” Five faculty members and five residents were also inducted into AΩA.
|
|
|
|
Eighteen members of the Larner Class of 2024 have been selected for induction into the Gold Humanism Honor Society (GHHS), recognized by their peers for their “demonstrated excellence in clinical care, leadership, compassion, and dedication to service.” In addition, one student and one faculty member were selected for the Leonard Tow Humanism in Medicine Award, announced in May.
|
|
|
|
UVM, in collaboration with the Larner College of Medicine, the College of Nursing and Health Sciences, the Division of Diversity, Equity, and Inclusion, and UVMHN, present the 2023 Health Equity Summit, “Closing the Margin: Avenues to Health Equity,” taking place October 29–30.
For full schedule and registration, click here.
|
|
|
Gramling R, Bennett E, Curtis K, Richards W, Rizzo DM, Arnoldy F, Hegg L, Porter J, Honstein H, Pratt S, Tarbi E, Reblin M, Thambi P, Agrawal M. Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin- Assisted Therapy: A Feasibility Study. J Palliat Med. 2023 Aug 17. doi: 10.1089/jpm.2023.0189. Epub ahead of print. PMID: 37590474.
|
Klemperer EM, Wreschnig L, Crocker A, King-Mohr J, Ramniceanu A, Brooklyn JR, Peck KR, Rawson RA, Evans EA. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose. J Subst Use Addict Treat. 2023 Sep;152:209103. doi: 10.1016/j.josat.2023.209103. Epub 2023 Jun 11. PMID: 37311520; PMCID: PMC10257572.
|
Petriceks AH, Appel LJ, Miller ER 3rd, Mitchell CM, Schrack JA, Mukamal KJ, Lipsitz LA, Wanigatunga AA, Plante TB, Michos ED, Juraschek SP. Timing of orthostatic hypotension and its relationship with falls in older adults. J Am Geriatr Soc. 2023 Sep 5. doi: 10.1111/jgs.18573. Epub ahead of print. PMID: 37668347.
|
Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher G, O'Meara ES, Miglioretti DL, Chen S, Lee JM, Stout NK, Mandelblatt JS, Alsheik N, Herschorn SD, Perry H, Weaver DL, Kerlikowske K. Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone. Cancer. 2023 Aug 15;129(16):2456-2468. doi: 10.1002/cncr.34768. Epub 2023 Jun 12. PMID: 37303202.
|
Strother CA, Brewer-Jensen PD, Becker-Dreps S, Zepeda O, May S, Gonzalez F, Reyes Y, McElvany BD, Averill AM, Mallory ML, Montmayeur AM, Costantini VP, Vinjé J, Baric RS, Bucardo F, Lindesmith LC, Diehl SA. Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters. Front Immunol. 2023 Aug 18;14:1229724. doi: 10.3389/fimmu.2023.1229724. PMID: 37662930; PMCID: PMC10471973.
|
Yip SW, Lichenstein SD, Liang Q, Chaarani B, Dager A, Pearlson G, Banaschewski T, Bokde ALW, Desrivières S, Flor H, Grigis A, Gowland P, Heinz A, Brühl R, Martinot JL, Martinot MP, Artiges E, Nees F, Orfanos DP, Paus T, Poustka L, Hohmann S, Millenet S, Fröhner JH, Smolka MN, Vaidya N, Walter H, Whelan R, Schumann G, Garavan H. Brain Networks and Adolescent Alcohol Use. JAMA Psychiatry. 2023 Aug 30:e232949. doi: 10.1001/jamapsychiatry.2023.2949. Epub ahead of print. PMID: 37647053; PMCID: PMC10469292.
|
|
|
WE WANT TO HEAR FROM YOU!
|
|
|
UVM LARNER COLLEGE OF MEDICINE
|
Published by the Office of Medical Communications © 2023
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
Given Building 89 Beaumont Ave | Burlington, VT 05405 US
|
|
| This email was sent to communicators@list.uvm.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
